Northern Trust’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-2,609
| Closed | -$15K | – | 4773 |
|
|
2022
Q2 | $15K | Hold |
2,609
| – | – | ﹤0.01% | 4658 |
|
|
2022
Q1 | $31K | Hold |
2,609
| – | – | ﹤0.01% | 4614 |
|
|
2021
Q4 | $27K | Hold |
2,609
| – | – | ﹤0.01% | 4685 |
|
|
2021
Q3 | $85K | Buy |
2,609
+337
| +15% | +$10.9K | ﹤0.01% | 4440 |
|
|
2021
Q2 | $97K | Hold |
2,272
| – | – | ﹤0.01% | 4368 |
|
|
2021
Q1 | $111K | Buy |
2,272
+155
| +7% | +$8.51K | ﹤0.01% | 4261 |
|
|
2020
Q4 | $74K | Buy |
+2,117
| New | +$66.5K | ﹤0.01% | 4177 |
|
|
2020
Q2 | – | Sell |
-249
| Closed | -$13K | – | 4318 |
|
|
2020
Q1 | $13K | Buy |
+249
| New | +$19.5K | ﹤0.01% | 4131 |
|
|
2019
Q3 | – | Sell |
-90
| Closed | -$24K | – | 4303 |
|
|
2019
Q2 | $24K | Hold |
90
| – | – | ﹤0.01% | 4153 |
|
|
2019
Q1 | $34K | Hold |
90
| – | – | ﹤0.01% | 4079 |
|
|
2018
Q4 | $34K | Sell |
90
-1
| -1% | -$392 | ﹤0.01% | 4110 |
|
|
2018
Q3 | $39K | Hold |
91
| – | – | ﹤0.01% | 4161 |
|
|
2018
Q2 | $33K | Hold |
91
| – | – | ﹤0.01% | 4172 |
|
|
2018
Q1 | $42K | Sell |
91
-53
| -37% | -$26.3K | ﹤0.01% | 4101 |
|
|
2017
Q4 | $83K | Buy |
144
+93
| +182% | +$61.3K | ﹤0.01% | 4006 |
|
|
2017
Q3 | $39K | Hold |
51
| – | – | ﹤0.01% | 4094 |
|
|
2017
Q2 | $43K | Sell |
51
-1
| -2% | -$731 | ﹤0.01% | 4098 |
|
|
2017
Q1 | $37K | Buy |
52
+10
| +24% | +$7.05K | ﹤0.01% | 4090 |
|
|
2016
Q4 | $30K | Buy |
42
+2
| +5% | +$1.62K | ﹤0.01% | 4062 |
|
|
2016
Q3 | $38K | Hold |
40
| – | – | ﹤0.01% | 4042 |
|
|
2016
Q2 | $58K | Hold |
40
| – | – | ﹤0.01% | 3990 |
|
|
2016
Q1 | $50K | Hold |
40
| – | – | ﹤0.01% | 4023 |
|
|
2015
Q4 | $52K | Hold |
40
| – | – | ﹤0.01% | 4044 |
|
|
2015
Q3 | $59K | Buy |
40
+3
| +8% | +$5.79K | ﹤0.01% | 4033 |
|
|
2015
Q2 | $81K | Sell |
37
-6
| -14% | -$18.8K | ﹤0.01% | 3981 |
|
|
2015
Q1 | $127K | Hold |
43
| – | – | ﹤0.01% | 3988 |
|
|
2014
Q4 | $144K | Hold |
43
| – | – | ﹤0.01% | 3899 |
|
|
2014
Q3 | $154K | Sell |
43
-193
| -82% | -$750K | ﹤0.01% | 3914 |
|
|
2014
Q2 | $908K | Sell |
236
-59
| -20% | -$222K | ﹤0.01% | 3430 |
|
|
2014
Q1 | $1.2M | Sell |
295
-33
| -10% | -$147K | ﹤0.01% | 3350 |
|
|
2013
Q4 | $1.22M | Sell |
328
-7
| -2% | -$26.5K | ﹤0.01% | 3335 |
|
|
2013
Q3 | $1.32M | Sell |
335
-4
| -1% | -$30K | ﹤0.01% | 3263 |
|
|
2013
Q2 | $3.35M | Buy |
+339
| New | +$3.76M | ﹤0.01% | 2671 |
|
Other funds holding FRTX
TI
PCM
TSS
TRCT
BTI
Northern Trust's FRTX Position: Q3 2022 in Review
Northern Trust sold out of Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) in Q3 2022, closing a stake of 2,609 shares — an estimated $15K sold.
Northern Trust first reported a position in FRTX in Q2 2013 and held it in 33 quarters. The position peaked at $3.35M in Q2 2013. 17 funds tracked by Wall St. Rank hold FRTX as of Q3 2022.
- Northern Trust reported no remaining Fresh Tracks Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
- Northern Trust sold 2,609 Fresh Tracks Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $15K.
- Northern Trust first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q2 2013 and held it in 33 quarters.
- Northern Trust's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $3.35M in Q2 2013.
- 17 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q3 2022.
Based on Northern Trust's 13F filing for Q3 2022, filed 14 Nov 2022.